Gestational trophoblastic neoplasia other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
2-[F-18]fluoro-2-deoxy-D-glucose (FDG)-PET scanning may be used to study the extent of malignancy in gestational trophoblastic neoplasia. | [[FDG-PET|2-[F-18]fluoro-2-deoxy-D-glucose (FDG)-PET]] scanning may be used to study the extent of [[malignancy]] in gestational trophoblastic neoplasia. | ||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
=== '''2-[F-18]fluoro-2-deoxy-D-glucose (FDG)-PET''' Scan === | === '''2-[F-18]fluoro-2-deoxy-D-glucose (FDG)-PET''' Scan === | ||
* 2-[F-18]fluoro-2-deoxy-D-glucose (FDG)-PET scanning may be used to study the extent of malignancy in gestational trophoblastic neoplasia.<ref name="SironiPicchio2003">{{cite journal|last1=Sironi|first1=S|last2=Picchio|first2=M|last3=Mangili|first3=G|last4=Garavaglia|first4=E|last5=Zangheri|first5=B|last6=Messa|first6=C|last7=Voci|first7=C|last8=Taccagni|first8=G.L|last9=Maschio|first9=A.Del|last10=Fazio|first10=F|title=[18f]fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumor: preliminary results in three patients|journal=Gynecologic Oncology|volume=91|issue=1|year=2003|pages=226–230|issn=00908258|doi=10.1016/S0090-8258(03)00437-2}}</ref><ref name="HebartErley1996">{{cite journal|last1=Hebart|first1=H.|last2=Erley|first2=C.|last3=Kaskas|first3=B.|last4=Mayer|first4=R.|last5=Konig|first5=M.|last6=Einsele|first6=H.|last7=Bokemeyer|first7=C.|last8=Meerpohl|first8=H. G.|last9=Feine|first9=U.|last10=Kanz|first10=L.|title=Positron emission tomography helps to diagnose tumor emboli and residual disease in chonocarcinoma|journal=Annals of Oncology|volume=7|issue=4|year=1996|pages=416–418|issn=0923-7534|doi=10.1093/oxfordjournals.annonc.a010611}}</ref> | * [[FDG-PET|2-[F-18]fluoro-2-deoxy-D-glucose (FDG)-PET]] scanning may be used to study the extent of [[malignancy]] in gestational trophoblastic neoplasia.<ref name="SironiPicchio2003">{{cite journal|last1=Sironi|first1=S|last2=Picchio|first2=M|last3=Mangili|first3=G|last4=Garavaglia|first4=E|last5=Zangheri|first5=B|last6=Messa|first6=C|last7=Voci|first7=C|last8=Taccagni|first8=G.L|last9=Maschio|first9=A.Del|last10=Fazio|first10=F|title=[18f]fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumor: preliminary results in three patients|journal=Gynecologic Oncology|volume=91|issue=1|year=2003|pages=226–230|issn=00908258|doi=10.1016/S0090-8258(03)00437-2}}</ref><ref name="HebartErley1996">{{cite journal|last1=Hebart|first1=H.|last2=Erley|first2=C.|last3=Kaskas|first3=B.|last4=Mayer|first4=R.|last5=Konig|first5=M.|last6=Einsele|first6=H.|last7=Bokemeyer|first7=C.|last8=Meerpohl|first8=H. G.|last9=Feine|first9=U.|last10=Kanz|first10=L.|title=Positron emission tomography helps to diagnose tumor emboli and residual disease in chonocarcinoma|journal=Annals of Oncology|volume=7|issue=4|year=1996|pages=416–418|issn=0923-7534|doi=10.1093/oxfordjournals.annonc.a010611}}</ref> | ||
* It may be useful in cases of occult disease of the lung parenchyma, pulmonary artery, liver and broad ligament when ultrasound, CT, MRI imaging results are equivocal.<ref name="NumnumLeath2005">{{cite journal|last1=Numnum|first1=T. Michael|last2=Leath|first2=Charles A.|last3=Straughn|first3=J. Michael|last4=Conner|first4=Michael G.|last5=Barnes|first5=Mack N.|title=Occult choriocarcinoma discovered by positron emission tomography/computed tomography imaging following a successful pregnancy|journal=Gynecologic Oncology|volume=97|issue=2|year=2005|pages=713–715|issn=00908258|doi=10.1016/j.ygyno.2005.01.049}}</ref> | * It may be useful in cases of occult disease of the [[lung]] parenchyma, [[pulmonary artery]], [[liver]] and [[Broad ligament of the uterus|broad ligament]] when [[ultrasound]], [[CT-scans|CT]], [[MRI]] imaging results are equivocal.<ref name="NumnumLeath2005">{{cite journal|last1=Numnum|first1=T. Michael|last2=Leath|first2=Charles A.|last3=Straughn|first3=J. Michael|last4=Conner|first4=Michael G.|last5=Barnes|first5=Mack N.|title=Occult choriocarcinoma discovered by positron emission tomography/computed tomography imaging following a successful pregnancy|journal=Gynecologic Oncology|volume=97|issue=2|year=2005|pages=713–715|issn=00908258|doi=10.1016/j.ygyno.2005.01.049}}</ref> | ||
==References== | ==References== | ||
Latest revision as of 20:05, 11 March 2019
|
Gestational trophoblastic neoplasia Microchapters |
|
Differentiating Gestational trophoblastic neoplasia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Gestational trophoblastic neoplasia other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Gestational trophoblastic neoplasia other diagnostic studies |
|
FDA on Gestational trophoblastic neoplasia other diagnostic studies |
|
CDC on Gestational trophoblastic neoplasia other diagnostic studies |
|
Gestational trophoblastic neoplasia other diagnostic studies in the news |
|
Blogs on Gestational trophoblastic neoplasia other diagnostic studies |
|
Directions to Hospitals Treating Gestational trophoblastic neoplasia |
|
Risk calculators and risk factors for Gestational trophoblastic neoplasia other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]
Overview
2-[F-18]fluoro-2-deoxy-D-glucose (FDG)-PET scanning may be used to study the extent of malignancy in gestational trophoblastic neoplasia.
Other Diagnostic Studies
2-[F-18]fluoro-2-deoxy-D-glucose (FDG)-PET Scan
- 2-[F-18]fluoro-2-deoxy-D-glucose (FDG)-PET scanning may be used to study the extent of malignancy in gestational trophoblastic neoplasia.[1][2]
- It may be useful in cases of occult disease of the lung parenchyma, pulmonary artery, liver and broad ligament when ultrasound, CT, MRI imaging results are equivocal.[3]
References
- ↑ Sironi, S; Picchio, M; Mangili, G; Garavaglia, E; Zangheri, B; Messa, C; Voci, C; Taccagni, G.L; Maschio, A.Del; Fazio, F (2003). "[18f]fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumor: preliminary results in three patients". Gynecologic Oncology. 91 (1): 226–230. doi:10.1016/S0090-8258(03)00437-2. ISSN 0090-8258.
- ↑ Hebart, H.; Erley, C.; Kaskas, B.; Mayer, R.; Konig, M.; Einsele, H.; Bokemeyer, C.; Meerpohl, H. G.; Feine, U.; Kanz, L. (1996). "Positron emission tomography helps to diagnose tumor emboli and residual disease in chonocarcinoma". Annals of Oncology. 7 (4): 416–418. doi:10.1093/oxfordjournals.annonc.a010611. ISSN 0923-7534.
- ↑ Numnum, T. Michael; Leath, Charles A.; Straughn, J. Michael; Conner, Michael G.; Barnes, Mack N. (2005). "Occult choriocarcinoma discovered by positron emission tomography/computed tomography imaging following a successful pregnancy". Gynecologic Oncology. 97 (2): 713–715. doi:10.1016/j.ygyno.2005.01.049. ISSN 0090-8258.